Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 397.00 | |
25 mg | In stock | $ 663.00 | |
50 mg | In stock | $ 945.00 | |
100 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 272.00 |
Description | CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer. |
Targets&IC50 | CD73:28 nM |
Synonyms | EX-A4254, LY-3475070 |
Molecular Weight | 286.33 |
Formula | C15H18N4O2 |
CAS No. | 2375815-63-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (78.58 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CD73-IN-3 2375815-63-5 Immunology/Inflammation CD73 Inhibitor cancer LY 3475070 CD73 IN 3 LY3475070 CD-73-IN-3 EX-A 4254 CD73IN3 EX-A-4254 EX-A4254 Immunosuppression tumor inhibit LY-3475070 inhibitor